Introduction to Gemcitabine and Its Market Significance Gemcitabine, a cornerstone of oncology treatment, is a nucleoside analog chemotherapy drug used primarily to combat pancreatic, breast, lung, ovarian, and bladder cancers. With global cancer incidence rising—with the World Health Organization (WHO) estimating 27.6 million new cases in 2025—with demand for effective chemotherapeutics like gemcitabine surging, pharmaceutical suppliers and manufacturers face a critical need to connect with reliable buyers. A robust gemcitabine global buyers list serves as a bridge between producers and end-users, enabling efficient market penetration, reducing sales cycles, and ensuring compliance with regional regulations. For suppliers, accessing verified buyers is not just about transactional success; it’s about aligning with healthcare…